Zenismart-G25 Ampoules (2ml Each)
Marketer
Zenis Pharma
Salt Composition
Glycopyrrolate (25mcg)
Overview Zenismart-G25 Ampoules (2ml Each)
G25 Ampoules (2ml each), marketed as Zenismart-G25, are indicated for managing chronic obstructive pulmonary disease (COPD). This medication promotes lung muscle relaxation, alleviating symptoms such as coughing, chest constriction, and dyspnea. Dosage frequency will be determined by your physician; utilize the lowest effective dose to manage your symptoms. While some benefit may be seen within days, full therapeutic effect typically takes several weeks. Consistent use is crucial for efficacy; discontinuation may exacerbate COPD symptoms. This medication is unsuitable for acute respiratory distress. Initial administration should be under medical observation due to the potential for bronchospasm. Common adverse effects include pharyngitis, xerostomia, gastroenteritis, and sleep disturbances. Consult your physician if these occur; dosage adjustment or alternative therapies may be considered. Prior to use, disclose any known allergies to product components and all pre-existing medical conditions, including details of all concurrent medications.
Uses of Zenismart-G25 Ampoules (2ml Each)
Managing Chronic Obstructive Pulmonary Disease (COPD)
Major Benefits of Zenismart-G25 Ampoules (2ml Each):
Follow your doctor's instructions or consult the product label for usage guidelines.
Common Side effects of Zenismart-G25 Ampoules (2ml Each):
- Sore throat
- Dryness in mouth
- Insomnia (difficulty in sleeping)
- Gastroenteritis
How to use Zenismart-G25 Ampoules (2ml Each):
Follow your doctor's instructions or consult the product label for usage guidelines.
How Zenismart-G25 Ampoules (2ml Each) works:
Each Zenismart-G25 ampoule (2ml) contains an anticholinergic agent that functions by inhibiting the action of acetylcholine, a neurotransmitter, within the central nervous system.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Zenismart-G25 Ampoules (2ml each) lacks established safety data. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Zenismart-G25 Ampoules (2ml each) during pregnancy is typically deemed safe. Preclinical trials in animals have indicated minimal or no harm to the fetus; nevertheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Zenismart-G25 Ampoules (2ml each) during breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, prolonged administration of Zenismart-G25 Ampoules (2ml each) may decrease breast milk supply.
DrivingNone
No known drug interactions.
KidneyNone
No known drug interactions.
LiverNone
No drug interactions identified.
What if you forget to take Zenismart-G25 Ampoules (2ml Each) :
NA
Facts to Know About Zenismart-G25 Ampoules (2ml Each)
| Label | Value |
|---|---|
| Chemical Type | Quaternary Ammonium Compounds (synthetic) |
| Developing Habits | No. |
| Treatment Category | Breathing |
| Actions | Anesthesia and Anticholinergics |
3,018 People bought this recently